Red cells coated with IgG globulin are bound circumferentially about a central mononuclear cell or monocyte into a "rosette" (1). Attached red cells appear deformed and closely resemble the abnormal red cell morphology frequently observed in the peripheral blood of patients with Coombs positive hemolytic anemia associated with IgG antibodies. Although in some studies the monocyte receptor was specific for IgG globulin without specificity for the third component of complement (C3) (1, 2), in others a receptor for C3 (3, 4) as well as a nonspecific receptor (5) have been described. We report here confirmation of the IgG specificity of the mononuclear cell receptor for rosette formation. A C3 receptor for rosette formation was not observed. Some of the well described biologic functions of the Fc fragment of IgG globulin reside in selective IgG subclasses (6). IgG subclass specificity for rosette formation is described in this report in addition to studies which further delineate the peptide portion of the Fc fragment of IgG that binds to the monocyte. 1
INTERACTION BETWEEN HU:v[AN MONOCYTES AND RED CELLS
pathic" cold agglutinin hemolytic anemia. Anti-Duffy, anti-Kidd, and anti-H isoantibodies were kindly provided. 2 IgG subclasses were purified from the sera of patients with multiple myeloma. 3 Purified heavy chains (3, 14 and "/36), purified from the urine of patients with heavy chain disease, were provided. T4 heavy chain was isolated from the pleural fluid of a patient with heavy chain disease. 5 In order to obtain fragments of IgG, IgG was first isolated from Cohn fraction II by elution from DEAE-cellulose with 0.007 ~ phosphate buffer, pH 6.3. Purified IgG was then reacted with cysteine-activated 1% papain according to previously described methods (7) . CM Sephadex chromatography was carried out with step-wise elutions from 0.01 ~ phosphate, pH 7.6, to 0.4 ~ NaC1-0.01 ~ phosphate, in order to separate Fc fragment contained in the first eluate from Fab fragment which was eluted in a late peak. Fc was separated from residual intact papain-resistant IgG by gel filtration (Sephadex G-100). The purity of the preparations was confirmed by immunoelectrophoresis using monospecific antibody (8) and by ultracentrifugation.
Reduction of Fc or heavy chains was carried out by reaction with 0.05 ~ dithiothreitol (DTT) 6 in 8 M urea 0.2 ~ tris (hydroxymethyl) amino-methane (Tris)-chloride buffer, pH 8.2 at 37°C for 4 hr. The reaction was completed by alkylation with 1.5 ~ excess iodoacetamide and dialysis against saline for 48 hr. Purified Fc and heavy chains were also treated with 8 urea alone at 37°C for 4 hr followed by dialysis against saline for 48 hr. F(ab')2 was prepared according to the methods of Nisonoff et al. (9) . Pepsin components II, III, and IV were produced by the digestion of purified IgG with 2% pepsin (10) and were separated by gel filtration (Sephadex G-75). Human serum albumin was obtained commercially. 7 Purified C3 was prepared from normal serum (11) and stored at -70°C.
Cells.--As previously described (12) , white cells were obtained from heparinized peripheral blood by dextran sedimentation, light centrifugation, and resuspension of the cell button in Hanks' balanced salt solution (containing 5 X 10 -4 ~ MgC12 and 1.3 X 10 -3 ~ CaC12). s Red ceils which were obtained from human blood (anticoagulated with heparin or acid-citratedextrose 9) were trace-radiolabeled with Na~51CrO4 (50-150 #Ci/ml whole blood) according to standard techniques (13) .
Attachment of Protein to Red Cells.--Red cells were washed with 80-100 volumes of Hanks' and brought to a 50% hematocrit. Equal volumes of these washed red cells and serum antibody (warm-type) were incubated for 1 hr at 37°C, after which they were rewashed in Hanks'. Purified proteins were also coupled to red cells nonspecifically using chromic chloride (14) . In this method, as previously described (12), a mixture was made of one part red cells (defibrinated blood washed six times with saline) at a 50% hematocrit, five parts of a protein solution (1 g/100 ml of saline), and two parts of chromic chloride (Cr +++) in saline (5 #moles Cr+++/ml of packed red cells for the coupling of mixed IgG or IgG subclasses). The Cr +++ solution was added last. After 4 rain at room temperature, the reaction was terminated by four saline washes. C3 was placed on red cells by two methods. In the first, 0.1 ml of washed normal red cells at a 4% hematocrit was incubated with 0.05 ml of fresh serum and 0.15 ml of serially diluted anti-Duffy or anti-Kidd antibody at 37°C for 2 hr, or with anti-H or anti-I antibody at 4°C overnight. After the initial incubation at either 37 ° or 4°C, the cells were washed and incubated in Hanks' at 37°C for 2 hr. Secondly, C3 was placed onto red cells in low ionic strength sucrose as previously described (15) . Detection of red cell coating with immunoglobulin or C3 was performed by Coombs testing with monospecific antisera (16) .
Incubation Technique.--To a vinyl cup 1° (~/~ inch diameter), 0.4 ml of the white cell suspension (10,000-20,000 white blood cells/mm 3) and 0.1 ml of Hanks' were added. After 45 min at 24°C the attached monolayer was rinsed with four washes of Hanks'. Test red cells (0.4 ml of a 5% hematocrit) and 0.1 ml of Hanks' were layered over the white cell monolayer. For rosette-inhibition experiments, 0.1 ml of the test protein was added in place of Hanks'. After 2 hr at 24°C unattached red cells were removed by four washes with Hanks'. Rosette formation or red cell binding was determined by light microscopy on wet preparations or after staining with Wright's solution. Quantitation of red cell binding was obtained by the release of radiolabeled hemoglobin after water lysis. For rosette-inhibition experiments, per cent inhibition was calculated as 100% minus the per cent uptake which occurred in the presence of test protein. Red cell adherance to monolayers which occurred in the absence of inhibiting protein was assumed to be 100% uptake.
TABLE I
Per Cent Inhibition of Rosette Formation 10 rag/100 14 rag/100 25 rag/100 50 rag/100 Free protein 2 rag/100 ml 5 mg/100 ml ml ml ml ml Rosette inhibition of anti-D-coated red ceils. Mixed (normal) IgG, IgG subclasses purified from the sera of patients with myeloma, and albumin were used at final concentrations which varied from 2 mg/100 ml to 50 mg/100 ml. Per cent inhibition equaled 100% minus the per cent uptake. The binding which occurred in the absence of protein was assumed to be 100% uptake.
RESULTS
Subclass Specificity.--Rosette-inhibition experiments were performed with anti-D-coated 51Cr-labeled red cells and free purified myeloma IgG subclasses (Table I ). The final concentration of inhibiting protein was varied from 2 mg/ 100 ml to 50 rag/100 ml. Mixed IgG was obtained from normal serum and presumably was comprised of the four IgG subc]asses in physiologic ratio. Mixed IgG inhibited rosette formation at all concentrations, whereas albumin resulted in no inhibition. IgG1 and IgG3 were effective inhibitors; IgG8 was slightly more inhibitory especially at the lowest concentration (2 mg/100 ml). IgG2 possessed the least inhibitory activity at the lower concentrations (2 rag/100 ml-10 rag/100 ml) and IgG4 was intermediate in inhibitory effect. In order to test for variation within an individua] IgG subclass, purified IgG1 10 Fabrikal Corp., Kalamazoo, Mich.
from six different patients with IgG1 myeloma were studied in rosette-inhibition experiments at a final concentration of 10 rag/100 ml. Rosette inhibition ranged from 71.1 to 82 % for the four kappa chain-specific myelomas and from 80.7 to 89.4% with the two lambda chain-specific proteins.
Heavy chains isolated from patients with heavy chain disease were also studied in rosette-inhibition experiments. 3"1 and 3"3 heavy chains inhibited rosette formation but 3"4 heavy chain had less inhibition (Table II) . Specificity of binding within the IgG subclass was also studied by measuring the binding to monolayers of red cells coupled with purified IgG subclasses by means of chromic chloride. The coupling of protein to red cells was confirmed by Coombs testing with purified subclass antisera, n Red cell binding to leukocyte monolayers was quantitated (Fig. 1 ) using Na251CrO4-1abeled red cells. Actual rosette formation was confirmed by light microscopy. Cells coated with IgG1 and IgG8 were bound to monolayers, but little adherence occurred with cells coated with IgG2 and IgG4.
Specificity of IgG Fragment.--In order to identify the portion of the IgG molecule which bound to the mononuclear cell, fragments of IgG were prepared and tested in rosette-inhibition experiments using anti-D-coated red cells. As shown in Table I I (18) . Since anti-D antibody is'reported to be composed of IgG1 and IgG3 molecules (19) , the inhibition of rosette formation by free IgG1 and IgG3 does not by itself indicate the selectivity of the receptor site for these antibody subclasses. However, when myeloma proteins of the various IgG subclasses were individually coupled to red cells, cells coated with IgGl and IgG3 formed rosettes, whereas those coated with IgG2 and IgG4 did not. Rosette-inhibition experiments using heavy chains isolated from patients with heavy chain disease confirm the specificity of heavy chains of "h and 71,3.
In order to delineate further the peptide region of gamma globulin responsible for binding to monocytes, several enzymatically produced peptides were studied for their capacity to inhibit rosette formation. (Fab~)2 was slightly inhibitory, whereas Fab fragments did not inhibit rosette formation. This small difference between (Fab')2 and Fab suggested that the attachment of anti-Dcoated cells was partly blocked by a portion of (Fab~)2 residing in the vicinity of the inter-heavy chain disulfide bond. This is consistent with the report that (Fab~)2 of anti-D, when attached to red ce]ls, formed rosettes, although not as effectively as with intact anti-D (18) . Pepsin component II, a noncovalently linked dimer of 116 amino acids of the C-terminal end of IgG, and smaller peptides, components III and IV, all failed to inhibit rosette formation.
When the disulfide bonds of Fc fragment or 3'1 heavy chain, isolated from the urine of a patient with heavy chain disease, were reduced and alkylated to yield single chains of Fc or 3'1 heavy chains, respectively, inhibition was abolished. Loss of inhibitory activity appeared not to be due to an alteration of tertiary structure since Fc and 3'1 heavy chains which were treated with 8 M urea retained full inhibitory activity. These studies suggested that the binding of IgG to the mononuclear cell occurred near the N-terminal end of the Fc portion of the molecule. In addition, inhibitory activity appeared to be dependent on the integrity of the inter-heavy chain disulfide bond. This observation is in accord with the findings of others working with complement fixation and passive cutaneous anaphylaxis (20, 21) . An alternate explanation is that reduction of intra-heavy chain disulfide bonds by DTT-induced conformational changes in the molecule which may have affected binding.
The monocyte receptor appeared to be somewhat more specific for IgG3 than for the other subclasses of IgG, as judged by rosette inhibition (at low protein c~ncentrations) and chromic chloride coupling experiments. Heavy chains of 3"3 were slightly less effective than intact IgG3 in rosette-inhibition experiments (Tables I and II) . This difference may reflect the known alteration in the number of disulfide bonds (22) or some other difference in amino acid sequence of the 3'3 heavy chain in this unusual disease.
Recently, a monocyte receptor for C3 has been reported (4) in a study in which heterologous antisera were used and enhancement of phagocytosis rather than rosette formation was described. In the experiments reported here, when C3 was "fixed" to cells by isoantibodies or aggregated to cells by suspension in low ionic sucrose medium, the red cells did not attach to mononuclear cells. In addition, the C3-coated cells from a patient deficient in the C3 inactivator (17) did not adhere to mononuclear cells. IgM agglutinins in the presence of complement have been observed to form mixed aggregates (12) , but red cells coated only with C3 did not adhere to monocytes. Cell-bound C3 may possess peptidase activity (23) , which appears to be critical for the mediation of phagocytosis (24) . It is possible that C3 enhances phagocytosis not because of a specific cellular receptor but rather because of the peptidase activity of activated C3. In this regard, LoBuglio (25) has recently demonstrated enhanced rosette formation by pretreatment of monocytes with various proteolytic enzymes.
Red cells coated with warm antibodies in some patients may survive normally, whereas in others a striking spherocytic hemolytic anemia occurs.
This difference and its relationship to subclass specificity of these antibodies is unknown. Perhaps the genetic or antigenic factors which direct the formation of the specific subclass of antibody may be important in determining which Coombs positive red cells will be altered in vivo and which will survive normally.
SUMMARY
Studies were carried out in order to characterize the specificity of IgG subclasses and IgG fragments for rosette formation using red cells and human mononuclear cells. Rosette formation of red cells coated with anti-D was inhibited by free IgG1 and IgG3; less inhibition occurred with IgG2 and IgG4. Red cells specifically coated with IgG1 and IgG3 by chromic chloride were bound to monocytes. Rosette inhibition of anti-D-coated red cells occurred with free Fc fragment of IgG globulin, and only partly with F(ab')2. Inhibitory capacity of Fc fragments of IgG and ~/1 heavy chain from heavy chain disease was reversed by the cleavage of disulfide bonds. No inhibition was noted with Fab, or with pepsin components II, III, or IV. These studies indicated that the mononuc]ear receptor was specific for IgG1 and IgGs. The peptide portion of IgG globulin which attached to the mononuclear cell appeared to reside in the N-terminal portion of the Fc fragment and also appeared to require the integrity of the inter-heavy chain disulfide bond. A specific receptor for C3 was not confirmed.
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